Alteration of Warfarin's Pharmacologic Properties in Clathrates with Glycyrrhizic Acid and Arabinogalactan Full article
| Journal |
Letters in Drug Design and Discovery
ISSN: 1570-1808 , E-ISSN: 1875-628X |
||||||
|---|---|---|---|---|---|---|---|
| Output data | Year: 2011, Volume: 8, Number: 3, Pages: 201-204 Pages count : 4 DOI: 10.2174/157018011794578222 | ||||||
| Tags | Arabinogalactan; Clathration; Glycyrrhizic acid; Warfarin | ||||||
| Authors |
|
||||||
| Affiliations |
|
Abstract:
The article describes the pharmacological examinations of clathrates of warfarin (WF) with glycyrrhizic acid (GA) and arabinogalactan (AG). A direct connection between the clathrate structure and the pharmacon's anticoagulative properties was observed. A 20 mg/kg (WF 2 mg/kg) dose of WF: GA 1:10 clathrate causes the increase in prothrombin time (PT) only in 54 hours, after 3 administrations. In contrast, a 20 mg/kg (WF 2 mg/kg) dose of WF: AG 1:10 clathrate leads to an increase in PT in 24 and 48 hours after a single administration, which corresponds to the effect of a comparator agent WF (2 mg/kg).
Cite:
Tolstikov T.G.
, Khvostov M.V.
, Lifshits G.I.
, Dushkin A.V.
, Meteleva E.S.
Alteration of Warfarin's Pharmacologic Properties in Clathrates with Glycyrrhizic Acid and Arabinogalactan
Letters in Drug Design and Discovery. 2011. V.8. N3. P.201-204. DOI: 10.2174/157018011794578222 WOS Scopus РИНЦ OpenAlex
Alteration of Warfarin's Pharmacologic Properties in Clathrates with Glycyrrhizic Acid and Arabinogalactan
Letters in Drug Design and Discovery. 2011. V.8. N3. P.201-204. DOI: 10.2174/157018011794578222 WOS Scopus РИНЦ OpenAlex
Dates:
| Published print: | Mar 1, 2011 |
Identifiers:
| Web of science: | WOS:000288983500001 |
| Scopus: | 2-s2.0-79952292772 |
| Elibrary: | 16664257 |
| OpenAlex: | W2334599523 |